Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Eli Lilly Covid-19 Antibody Treatment Trial Is Paused Due To 'Potential Safety Concern'

Forbes - 13 Oct 2020 23:11
Eli Lilly Covid-19 Antibody Treatment Trial Is Paused Due To 'Potential Safety Concern' President Trump has promoted the company's antibody treatment in recent videos.
Full Article at Forbes

More Business News
2
0
0


Storyboard
Print
Share this Article



Comment on this Article

Please Sign In to comment

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard